Login


TI Ref No : 528433426
Description : Acquisition Of The Medication Pembrolizumab [25 Mg/ Ml;4 Ml; Sol Inj; Frs] For The Ulscb contract Date: : 02-02-2026 contract Price: 51.150,00 € deadline: 345 Dias place Of Execution: Portugal.acquisition Of The Medication Pembrolizumab [25 Mg/ Ml;4 Ml; S
Date : 2026-02-04
Deadline : 2026-05-02
Document Type : Contracts
View Details
Whats app